SONN icon

Sonnet BioTherapeutics
SONN

Overview Fund Trends Analyst Outlook Journalist POV

13 hedge funds and large institutions have $1.69M invested in Sonnet BioTherapeutics in 2021 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding: →

more capital invested

Capital invested by funds: $ → $

less ownership

Funds ownership: →

Holders
13
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$651K
2
+$292K
3
+$70K
4
TSS
Two Sigma Securities
New York
+$22K
5
BPA
Beacon Pointe Advisors
California
+$11K

Top Sellers

1
-$2K
2
-$1.54K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.08M
2
$301K
3
$111K
4
$70K
5
$38K
6
$27K
7
$22K
8
$20K
9
$11K
10
$7K
11
$6K
12
$1K
13
$1K
14
–